BIOCON:NSE
Biocon Ltd
₹ 349.20
arrow_downward
-0.80%(-2.80) Siku 1
16 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BIOCON...
Fungua
₹ 352.60
Juu
₹ 353.00
Chini
₹ 348.00
Mtaji wa soko
568.79B
Wastani wa kiasi cha mauzo
2.97M
Kiasi cha mauzo ya hisa
1.88M
Gawio
0.14%
Mgawo wa faida wa kila robo mwaka
₹ 0.12
Tarehe ya kutojumuisha gawio
3 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
103.38
Juu kwa wiki 52
₹ 447.15
Chini kwa wiki 52
₹ 337.70
EPS
₹ 3.38
Hisa za wawekezaji
600.00M
Idadi ya wafanyakazi
elfu 16
Fungua
₹ 352.60
Juu
₹ 353.00
Chini
₹ 348.00
Mtaji wa soko
568.79B
Wastani wa kiasi cha mauzo
2.97M
Kiasi cha mauzo ya hisa
1.88M
Gawio
0.14%
Mgawo wa faida wa kila robo mwaka
₹ 0.12
Tarehe ya kutojumuisha gawio
3 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
103.38
Juu kwa wiki 52
₹ 447.15
Chini kwa wiki 52
₹ 337.70
EPS
₹ 3.38
Hisa za wawekezaji
600.00M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
dakika 23 zilizopita
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
Binance
·
dakika 12 zilizopita
Binance Market Update | S&P 500 Near a Record While Half the Russell 3000 Is in a Bear Market — Bitcoin Held as AI Credit Spreads Blew Out and Strategy Fell 9%
ChartMill
·
dakika 55 zilizopita
HONGLI GROUP INC (NASDAQ:HLP) Passes Minervini Trend Template and High-Growth Momentum Screen
MarketWatch
·
saa 13 zilizopita
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Wasifu
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Kuhusu Biocon Ltd
Afisa Mkuu Mtendaji (CEO)Shreehas P Tambe
Wafanyakazielfu 16.4
Lilianzishwa29 Nov 1978
Makao makuuBangalore, Karnataka, India
Sekta-
Tovutibiocon.com